Last reviewed · How we verify
LY3410738
At a glance
| Generic name | LY3410738 |
|---|---|
| Sponsor | Eli Lilly and Company |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations (PHASE1)
- Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations (PHASE1)
- A Study of LY3410738 in Healthy Adult Participants (PHASE1)
- A Study Comparing Different Formulations of LY3410738 in Healthy Adult Participants (PHASE1)
- Study of the Effects of Itraconazole and Carbamazepine on LY3410738 in Healthy Participants (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |